Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Listen Carefully to Dr. Shaf Keshavjee (UHN Sprott Surgery)
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(800)
•••
Comment by SouthernTierTomon Dec 31, 2020 9:42am
93 Views
Post# 32202600

RE:Listen Carefully to Dr. Shaf Keshavjee (UHN Sprott Surgery)

RE:Listen Carefully to Dr. Shaf Keshavjee (UHN Sprott Surgery)Money and science...the "market" looks like it is receptive to the first of many cash infusions from the "3 wisemen"!

GREAT piece from Dr. Shaf, this gent is the "worthe the price of admission" here at SQIDF!

Listen Carefully to Dr. Shaf Keshavjee (UHN Sprott Surgery)

UHN & Shaf are creating an industry that never existed, and SQI Diagnostics is an important part of it.  Organ procurement = Multi Billion dollar industry, and thats just to start.  Shaf has a vision that will take things well beyond Lungs.  His ideas and actions will ultimately make a huge difference for so many.  Shaf is saving lives and creating new industries....Amazing human being.    

Personalized/Precision Medicine can't exist without Diagnostics.  
Just a matter of time before word gets out.  
SHH - This is a 2021 story, not a 2020 story.  

Once you have digested, please share any thoughts.  

2020 Governor General's Innovation Award recipient Dr. Shaf ...m.facebook.com › tgwhf › videos

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities